European Journal of Pharmaceutics and Biopharmaceutics
Praise for previous volumes... ...serve[s] as a text book for advanced students and as a reference for all pharmacists (and other professionals who are engaged in this area...recommended to all formulators, as well as scientists and teachers, seeking for a source of quick and comprehensive information about general aspects of disperse system dosage forms.
Journal of Controlled Release
...recommend[ed]...for inclusion into a department reference library, or its use in an academic course because of its broad approach in some areas, such as polymeric coating and nanoparticle development, as well as its specific focus on certain areas such as scale-up and liposomes.
Journal of the American Chemical Society
...a valuable resource with plenty of useful tips and insights.
Pharmaceutical Research
...these books are indispensable for those pharmaceutical scientists involved in the development of disperse dosage forms...[they] will also be very helpful in teaching...there is no doubt that these books will serve as valuable reference books for the years to come.
Booknews
The second (of three) volume of substantially revised second-edition coverage of disperse systems (each of two other subjects, tablets and parenteral medications, are also contained in three volumes). Twelve chapters discuss pharmaceutical suspensions; emulsions and microemulsions; antacids and clay products; oral aqueous, topical, reconstitutable suspensions; injectable and aerosol suspensions and emulsions; ophthalmic ointments and suspensions; gels; toothpastes; and suppository development and production. Annotation c. Book News, Inc., Portland, OR (booknews.com)
Booknews
The third and final volume on disperse systems contains contributions from both the academic and business sides of the pharmaceutical industry. Part A details several specialized products such as certain types of emulsions, liposomes, polymers used in dispersions as either drug or film carriers, biodegradable and new polymeric dispersions, and the characteristics of polymeric pharmaceutical excipents currently used in drug formulations. Part B describes equipment selection and processing, scale-up manufacturing, quality assurance, validation, and drug regulatory affairs related to disperse system pharmaceutical products and dosage forms. Annotation c. by Book News, Inc., Portland, Or.
